Sinopep
Nanjing, China· Est.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
Overview
Integrated peptide specialist developing therapeutics for metabolic diseases.
Metabolic
Technology Platform
Integrated platform for the research, development, and GMP manufacturing of peptide-based therapeutics using advanced synthesis techniques.
Opportunities
Potential to leverage its manufacturing expertise to become a leading global CDMO for peptide therapies.
Risk Factors
Pipeline heavily weighted towards generics and biosimilars, exposing it to pricing erosion and competition.
Competitive Landscape
A well-established domestic player in peptides but faces intense competition from global leaders in the metabolic disease space.